C57BL/6-Tg(Itgax-BCL2)1Ple/Orl

Status

Available to order

EMMA IDEM:04747
International strain nameC57BL/6-Tg(Itgax-BCL2)1Ple/Orl
Alternative nameTg CD11c-hBcl2
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Itgax-BCL2)1Ple
Gene/Transgene symbolTg(Itgax-BCL2)1Ple

Information from provider

Providerphilippe Lesnik
Provider affiliationINSERM Unit 939, Hôpital de la Pitié-Salpêtrière
Genetic informationhBcl-2 cDNA from pORF-hBcl-2 (Invivogen) was cloned downstream of the mouse dendritic cell-specific promoter Cd11c (Itgax) up to 821 bp from the ATG codon, amplified from a mouse BAC clone (BACPAC Resources). The linearized transgenic construct was injected into C57BL/6 fertilized female pronuclei, and progeny positive for the transgene were crossed to C57BL/6 mice. Of the three founders obtained, one animal gave germline transmission.
Phenotypic informationConventional dendritic cells with enhanced longevity. Immune system is functional. The percentage of dendritic cells in the spleen is increased.
Breeding historyThe linearized transgenic construct was injected into C57BL/6 fertilized female pronuclei, and progeny positive for the transgene were crossed to C57BL/6.
References
  • Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock.;Gautier Emmanuel L, Huby Thierry, Saint-Charles Flora, Ouzilleau Betty, Chapman M John, Lesnik Philippe, ;2008;Journal of immunology (Baltimore, Md. : 1950);180;6941-6; 18453615
  • Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.;Gautier Emmanuel L, Huby Thierry, Saint-Charles Flora, Ouzilleau Betty, Pirault John, Deswaerte Virginie, Ginhoux Florent, Miller Elizabeth R, Witztum Joseph L, Chapman M John, Lesnik Philippe, ;2009;Circulation;119;2367-75; 19380622
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous 0, wild-type C57BL/6J
Breeding at archiving centreTransgenic males crossed with wild-type females.

Literature references

  • Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock.;Gautier Emmanuel L, Huby Thierry, Saint-Charles Flora, Ouzilleau Betty, Chapman M John, Lesnik Philippe, ;2008;Journal of immunology (Baltimore, Md. : 1950);180;6941-6; 18453615
  • Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.;Gautier Emmanuel L, Huby Thierry, Saint-Charles Flora, Ouzilleau Betty, Pirault John, Deswaerte Virginie, Ginhoux Florent, Miller Elizabeth R, Witztum Joseph L, Chapman M John, Lesnik Philippe, ;2009;Circulation;119;2367-75; 19380622

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).